3rd Quarter - Report
THORN RUN PARTNERS for HARMONY BIOSCIENCES
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Issues related to the orphan drug tax credit. Build Back Better: S. Con. Res. 14, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BEAU SCHUYLER | Legislative Director: Rep. Tanner; Legislative Director: Rep. McIntyre |
Health Issues HCR
Issues related to the development of therapies for rare diseases. Issues regarding drug pricing. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREW ROSENBERG | — |
| BEAU SCHUYLER | Legislative Director: Rep. Tanner; Legislative Director: Rep. McIntyre |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.